We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

HospiMedica

Download Mobile App
Recent News AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

Immune Imbalance in the Gut May Trigger Celiac Disease

By HospiMedica International staff writers
Posted on 24 Feb 2011
A new study claims that people who have high levels of Interleukin-15 may be primed to develop celiac disease (CD), a digestive disorder that keeps sufferers from eating foods like cereal, pasta, cookies, and beer.

Researchers at the University of Chicago (IL, USA) integrated insights from immunological studies with results of recent genetic genome-wide association studies into a disease model. The researchers claim that genetic data, among others, suggest that viral infections are implicated and that a natural effector pathway is important in the pathogenesis of CD. However, these data also converge with existing immunological findings that CD is primarily a T cell-mediated immune disorder in which CD4(+) T cells that recognize gluten peptides play a central role, via disregulation of Interleukin-15.

To study the CD pathway hypothesis, the researchers recreated the disease in mice by increasing levels of Interleukin-15 in their intestines. Once this occurred, the mice developed all the early symptoms of CD. Adding retinoic acid to the mix only made the symptoms worse, causing inflammation and tissue damage. When the researchers blocked IL-15, however, the CD mice reverted to normal and were once again able to tolerate gluten. The study was published ahead of print on February 9, 2011, in Nature. The suggested pathway is discussed further in 2011 Annual Review of Immunology.

"We still don't understand why Interleukin-15 is disregulated; if there is a disregulation in the intestinal environment, this alone can explain how you can lose tolerance to some food items,” said lead author Bana Jabri, MD, PhD, of the digestive disease research core center. "It is a first time a pathway has been identified; having mice that develop the disease will allow the team to study potential treatments.”

CD is an autoimmune disorder of the small intestine, caused by a reaction to gliadin--a gluten protein found in wheat--and similar proteins found in the Triticeae crops, which includes other common grains such as barley and rye. However, a comparison of genetic pathways as well as genetic susceptibility loci between CD and other autoimmune and inflammatory disorders reveals that CD bears stronger resemblance to T cell-mediated organ-specific autoimmune than to inflammatory diseases.

Related Links:

University of Chicago



Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Silver Member
Compact 14-Day Uninterrupted Holter ECG
NR-314P
New
Radial Shock Wave Device
MASTERPULS »ultra«

Latest Critical Care News

On-Skin Wearable Bioelectronic Device Paves Way for Intelligent Implants

First-Of-Its-Kind Dissolvable Stent to Improve Outcomes for Patients with Severe PAD

AI Brain-Age Estimation Technology Uses EEG Scans to Screen for Degenerative Diseases